Skip to main content
Top
Published in: Tumor Biology 3/2015

01-03-2015 | Research Article

MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression

Authors: Fei Shen, Wen-Song Cai, Zhe Feng, Jiang-Lin Li, Ji-Wei Chen, Jie Cao, Bo Xu

Published in: Tumor Biology | Issue 3/2015

Login to get access

Abstract

MicroRNAs (miRNAs) have emerged as important regulators that potentially play critical roles in cancer cell biological processes. Previous studies have shown that miR-492 plays an important role in cell tumorigenesis in multiple kinds of human cancer cells. However, the underlying mechanisms of this microRNA in breast cancer remain largely unknown. In the present study, we investigated miR-492’s role in cell proliferation of breast cancer. MiR-492 expression was markedly upregulated in breast cancer tissues and breast cancer cells. Overexpression of miR-492 promoted the proliferation and anchorage-independent growth of breast cancer cells. Bioinformatics analysis further revealed sex-determining region Y-box 7 (SOX7), a putative tumor suppressor, as a potential target of miR-492. Data from luciferase reporter assays showed that miR-492 directly binds to the 3′-untranslated region (3′-UTR) of SOX7 messenger RNA (mRNA) and repressed expression at both transcriptional and translational levels. Ectopic expression of miR-492 led to downregulation of SOX7 protein, which resulted in the upregulation of cyclin D1 and c-Myc. In functional assays, SOX7 silenced in miR-492-in-transfected ZR-75-30 cells has positive effect to promote cell proliferation, suggesting that direct SOX7 downregulation is required for miR-492-induced cell proliferation and cell cycle of breast cancer. In sum, these results suggest that miR-492 represents a potential onco-miR and participates in breast cancer carcinogenesis by suppressing SOX7 expression.
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed
2.
go back to reference Dalmay T. Mechanism of miRNA-mediated repression of mRNA translation. Essays Biochem. 2013;54:29–38.CrossRefPubMed Dalmay T. Mechanism of miRNA-mediated repression of mRNA translation. Essays Biochem. 2013;54:29–38.CrossRefPubMed
3.
go back to reference van Kouwenhove M, Kedde M, Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer. 2011;11:644–56.CrossRefPubMed van Kouwenhove M, Kedde M, Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer. 2011;11:644–56.CrossRefPubMed
4.
5.
go back to reference Li P, Xie XB, Chen Q, Pang GL, Luo W, Tu JC, et al. MiRNA-15a mediates cell cycle arrest and potentiates apoptosis in breast cancer cells by targeting synuclein-gamma. Asian Pac J Cancer Prev: APJCP. 2014;15:6949–54.CrossRefPubMed Li P, Xie XB, Chen Q, Pang GL, Luo W, Tu JC, et al. MiRNA-15a mediates cell cycle arrest and potentiates apoptosis in breast cancer cells by targeting synuclein-gamma. Asian Pac J Cancer Prev: APJCP. 2014;15:6949–54.CrossRefPubMed
6.
go back to reference Krutilina R, Sun W, Sethuraman A, Brown M, Seagroves TN, Pfeffer LM, et al. MicroRNA-18a inhibits hypoxia-inducible factor 1-alpha activity and lung metastasis in basal breast cancers. Breast Cancer Res. 2014;16:R78.CrossRefPubMedPubMedCentral Krutilina R, Sun W, Sethuraman A, Brown M, Seagroves TN, Pfeffer LM, et al. MicroRNA-18a inhibits hypoxia-inducible factor 1-alpha activity and lung metastasis in basal breast cancers. Breast Cancer Res. 2014;16:R78.CrossRefPubMedPubMedCentral
8.
go back to reference Zhang W, Liu J, Wang G. The role of microRNAs in human breast cancer progression. Tumour Biol J Int Soc Oncodev Biol Med. 2014;35:6235–44.CrossRef Zhang W, Liu J, Wang G. The role of microRNAs in human breast cancer progression. Tumour Biol J Int Soc Oncodev Biol Med. 2014;35:6235–44.CrossRef
9.
go back to reference von Frowein J, Pagel P, Kappler R, von Schweinitz D, Roscher A. MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma. Hepatology (Baltimore, Md). 2011;53:833–42.CrossRef von Frowein J, Pagel P, Kappler R, von Schweinitz D, Roscher A. MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma. Hepatology (Baltimore, Md). 2011;53:833–42.CrossRef
10.
go back to reference Zhao JJ, Yang J, Lin J, Yao N, Zhu Y, Zheng J, et al. Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst: ChNS: Off J Int Soc Pediatr Neurosurg. 2009;25:13–20.CrossRef Zhao JJ, Yang J, Lin J, Yao N, Zhu Y, Zheng J, et al. Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst: ChNS: Off J Int Soc Pediatr Neurosurg. 2009;25:13–20.CrossRef
11.
go back to reference Hui AB, Lin A, Xu W, Waldron L, Perez-Ordonez B, Weinreb I, et al. Potentially prognostic miRNAs in HPV-associated oropharyngeal carcinoma. Clin Cancer Res: Off J Am Assoc Cancer Res. 2013;19:2154–62.CrossRef Hui AB, Lin A, Xu W, Waldron L, Perez-Ordonez B, Weinreb I, et al. Potentially prognostic miRNAs in HPV-associated oropharyngeal carcinoma. Clin Cancer Res: Off J Am Assoc Cancer Res. 2013;19:2154–62.CrossRef
12.
go back to reference Wu GG, Li WH, He WG, Jiang N, Zhang GX, Chen W, et al. MiR-184 post-transcriptionally regulates SOX7 expression and promotes cell proliferation in human hepatocellular carcinoma. PLoS One. 2014;9:e88796.CrossRefPubMedPubMedCentral Wu GG, Li WH, He WG, Jiang N, Zhang GX, Chen W, et al. MiR-184 post-transcriptionally regulates SOX7 expression and promotes cell proliferation in human hepatocellular carcinoma. PLoS One. 2014;9:e88796.CrossRefPubMedPubMedCentral
13.
go back to reference Chan DW, Mak CS, Leung TH, Chan KK, Ngan HY. Down-regulation of SOX7 is associated with aberrant activation of Wnt/β-catenin signaling in endometrial cancer. Oncotarget. 2012;3:1546–56.CrossRefPubMedPubMedCentral Chan DW, Mak CS, Leung TH, Chan KK, Ngan HY. Down-regulation of SOX7 is associated with aberrant activation of Wnt/β-catenin signaling in endometrial cancer. Oncotarget. 2012;3:1546–56.CrossRefPubMedPubMedCentral
14.
go back to reference Zhang Y, Huang S, Dong W, Li L, Feng Y, Pan L, et al. SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells. Cancer Lett. 2009;277:29–37.CrossRefPubMed Zhang Y, Huang S, Dong W, Li L, Feng Y, Pan L, et al. SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells. Cancer Lett. 2009;277:29–37.CrossRefPubMed
15.
go back to reference Rajabi HN, Takahashi C, Ewen ME. Retinoblastoma protein and MyoD function together to effect the repression of fra-1 and in turn cyclin D1 during terminal cell cycle arrest associated with myogenesis. J Biol Chem. 2014;289:23417–27.CrossRefPubMedPubMedCentral Rajabi HN, Takahashi C, Ewen ME. Retinoblastoma protein and MyoD function together to effect the repression of fra-1 and in turn cyclin D1 during terminal cell cycle arrest associated with myogenesis. J Biol Chem. 2014;289:23417–27.CrossRefPubMedPubMedCentral
16.
go back to reference Cui J, Xi H, Cai A, Bian S, Wei B, Chen L. Decreased expression of SOX7 correlates with the upregulation of the Wnt/beta-catenin signaling pathway and the poor survival of gastric cancer patients. Int J Mol Med. 2014;34:197–204.PubMed Cui J, Xi H, Cai A, Bian S, Wei B, Chen L. Decreased expression of SOX7 correlates with the upregulation of the Wnt/beta-catenin signaling pathway and the poor survival of gastric cancer patients. Int J Mol Med. 2014;34:197–204.PubMed
17.
go back to reference Stovall DB, Wan M, Miller LD, Cao P, Maglic D, Zhang Q, et al. The regulation of SOX7 and its tumor suppressive role in breast cancer. Am J Pathol. 2013;183:1645–53.CrossRefPubMedPubMedCentral Stovall DB, Wan M, Miller LD, Cao P, Maglic D, Zhang Q, et al. The regulation of SOX7 and its tumor suppressive role in breast cancer. Am J Pathol. 2013;183:1645–53.CrossRefPubMedPubMedCentral
18.
go back to reference Stovall DB, Cao P, Sui G. SOX7: from a developmental regulator to an emerging tumor suppressor. Histol Histopathol. 2014;29:439–45.PubMed Stovall DB, Cao P, Sui G. SOX7: from a developmental regulator to an emerging tumor suppressor. Histol Histopathol. 2014;29:439–45.PubMed
19.
go back to reference He M, Li Y, Zhang L, Li L, Shen Y, Lin L, et al. Curcumin suppresses cell proliferation through inhibition of the Wnt/beta-catenin signaling pathway in medulloblastoma. Oncol Rep. 2014;32:173–80.PubMed He M, Li Y, Zhang L, Li L, Shen Y, Lin L, et al. Curcumin suppresses cell proliferation through inhibition of the Wnt/beta-catenin signaling pathway in medulloblastoma. Oncol Rep. 2014;32:173–80.PubMed
20.
go back to reference Zhi X, Tao J, Xie K, Zhu Y, Li Z, Tang J, et al. Muc4-induced nuclear translocation of beta-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer. Cancer Lett. 2014;346:104–13.CrossRefPubMed Zhi X, Tao J, Xie K, Zhu Y, Li Z, Tang J, et al. Muc4-induced nuclear translocation of beta-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer. Cancer Lett. 2014;346:104–13.CrossRefPubMed
21.
go back to reference Lee MA, Park HJ, Chung HJ, Kim WK, Lee SK. Antitumor activity of 2-hydroxycinnamaldehyde for human colon cancer cells through suppression of beta-catenin signaling. J Nat Prod. 2013;76:1278–84.CrossRefPubMed Lee MA, Park HJ, Chung HJ, Kim WK, Lee SK. Antitumor activity of 2-hydroxycinnamaldehyde for human colon cancer cells through suppression of beta-catenin signaling. J Nat Prod. 2013;76:1278–84.CrossRefPubMed
22.
go back to reference Arabi A, Wu S, Ridderstrale K, Bierhoff H, Shiue C, Fatyol K, et al. c-Myc associates with ribosomal DNA and activates RNA polymerase i transcription. Nat Cell Biol. 2005;7:303–10.CrossRefPubMed Arabi A, Wu S, Ridderstrale K, Bierhoff H, Shiue C, Fatyol K, et al. c-Myc associates with ribosomal DNA and activates RNA polymerase i transcription. Nat Cell Biol. 2005;7:303–10.CrossRefPubMed
23.
go back to reference Grewal SS, Li L, Orian A, Eisenman RN, Edgar BA. Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development. Nat Cell Biol. 2005;7:295–302.CrossRefPubMed Grewal SS, Li L, Orian A, Eisenman RN, Edgar BA. Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development. Nat Cell Biol. 2005;7:295–302.CrossRefPubMed
Metadata
Title
MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression
Authors
Fei Shen
Wen-Song Cai
Zhe Feng
Jiang-Lin Li
Ji-Wei Chen
Jie Cao
Bo Xu
Publication date
01-03-2015
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 3/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2794-z

Other articles of this Issue 3/2015

Tumor Biology 3/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine